quote:

---

Originally posted by Upside:
I'm considering a position in this one based on the companys recent p/r's about OTCBB registration and the sales of their Mastascope. I'd like to find out some more about the company but am finding it difficult to turn up anything other than what anyone can find on the companys web site. Based on that, it looks like an awfully promising company. Can anyone offer up any more information?

---

In a message dated 6/6/2004 8:10:10 PM Pacific Standard Time, xxxx@xx.xxx writes:

Dear Mr. Stock,
I am considering an investment in Lifeline but I was wondering if you could answer a few questions first. I realize that you may not be able to answer some of them but would appreciate any help you can give me.

Question #1, I noticed that approximately 1 year ago you had a reverse split which took the outstanding share count down to approximately 82 million. Has this remained constant or have more shares been issued?

Question #2, I see you are attempting to obtain an OTCBB listing. Any speculation as to the timeline of this process?

Question #3, Can you give me any sales numbers for your various products or sales projections for the remainder of this year?

I thank you for taking the time to read this and anxiously await your response.

Sincerely,

Xxxx Xxxxxxxx

Dear Xxxx:

Thank you for your questions re: LBTT.

In order, #1) Yes, more shares were issued via Private Placement stock since the reverse split in 2003. The current number of share issued/outstanding is 996 million.

#2) The timeline is roughly by the end of this calendar year. The SEC must bless this filing, and their approval process is not easily predictable.

#3) The only information re: revenues that I have are reflected int he company's 4-28-2004 press release, reprinted below, FYI.

Thank you for your support in the company,
and write again at any time.

Jim Stock
LBTT investor relations

For Immediate Release

LIFELINE BIOTECHNOLOGIES, INC. HOLDS NATIONAL SALES MEETING FOR ORTHOPEDICS DIVISION ESTABLISHING SALES EXPECTATIONS

RENO, Nevada - April 28, 2004 - Jim Holmes, CEO of Lifeline Biotechnologies, Inc. (LBTT.OTC) today announced the Company has assigned second quarter sales quotas to its distributor organization and a result of the recent orthopedic division sales meeting. This sales meeting was well attended by Lifeline’s distributor organization. Holmes said “sales could exceed half a million dollars during this quarter. This would be a significant increase in sales compared to the approximate $100,000 in shipments to date.” Holmes further commented “sales, for the orthopedics division, could be running at an annual rate of approximately five million dollars by the end of this year.”

Jonathan Reeves, Lifeline’s Vice President of Operations, added “Our first national sales training meeting was a great success and we are fortunate this meeting preceded the Arthroscopic Association of North America Conference where we were able to generate an outstanding number of quality sales leads.”

Bruce Look, Lifeline’s US Director of Sales, said that “a large number of the country’s top arthroscopic surgeons, who are heads of departments of both hospitals and medical schools in orthopedic surgery and sports medicine, stopped at our booth. Many of them were impressed and expressed an interest in trying the orthopedic shaver blade and bioabsorbable screw lines Lifeline represents. Many of those physicians are part owners of surgery centers and were very enthusiastic with regard to the cost saving prospects for their facility utilizing the shaver blade line. The Hexalon ACL/PCL Screw generated additional interest, because of extraordinary physical and design characteristics, which make Hexalon screws an ideal replacement for the traditional metal and absorbable screws presently used in ACL/PCL repairs. The physicians were impressed with the screw's strength, which was demonstrated by driving the screw into a block of plywood with a mallet and then removing the screw with a screwdriver revealing no damage to the screw.” Look went on to comment, “These leads are as ‘solid’ as any leads I’ve seen in my thirty years of sales experience in the medical field.”

Lifeline's website address: www.lbti.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe," "expects," "projects," "forecasts," "intends," "will," "anticipated," "could," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and subject to the safe harbor created by the act. Except for historical information, all of the statements contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.

--------------------------------------------------------------------------------

Contact:

Lifeline Biotechnologies, Inc.

Jim Holmes, 775-324-1933

jholmes@lbti.com

Stock Enterprises

Investor Relations

Jim Stock, 866-242-2405

I do not have a large position in anything but this one looks great long term to me.

Has several products they offer that are generating revenue already.

Blades, breast scope.

I understand that they have other products in mind for later also.

I think this one is an easy 10 bagger and maybe 20. Lo0ng term who knows where it will go.

Should be off the PINK soon, this will be great.

-----------------
UPSIDE

What about the big OS, have you run any numbers to see where that puts this one?

PAUL

PAUL